RNA editing of Filamin A pre‐mRNA regulates vascular contraction and diastolic blood pressure

Mamta Jain(Medical University of Vienna), Tomer Mann(Bar-Ilan University), Maja Stulić(Medical University of Vienna), Shailaja Rao(Medical University of Graz), Andrijana Kirsch(Medical University of Graz), Dieter Pullirsch(Medical University of Vienna), Xué Strobl(Medical University of Vienna), Claus Rath(Medical University of Vienna), Lukas F. Reissig(Medical University of Vienna), Kristin Moreth(Helmholtz Zentrum München), Tanja Klein‐Rodewald(Helmholtz Zentrum München), Raffi Bekeredjian(Heidelberg University), Valérie Gailus‐Durner(Helmholtz Zentrum München), Helmut Fuchs(Helmholtz Zentrum München), Martin Hrabě de Angelis(Helmholtz Zentrum München), Eleonore Pablik(Medical University of Vienna), Laura Cimatti(Medical University of Vienna), David I. K. Martin(Medical University of Vienna), Jelena Lazović(Vienna Biocenter), Wolfgang F. Graier(Medical University of Graz), Maria Sibilia(Comprehensive Cancer Center Vienna), Saša Frank(Medical University of Graz), Erez Y. Levanon(Bar-Ilan University), Michael F. Jantsch(Medical University of Vienna)
The EMBO Journal
August 7, 2018
Cited by 121Open Access
Full Text

Abstract

Epitranscriptomic events such as adenosine-to-inosine (A-to-I) RNA editing by ADAR can recode mRNAs to translate novel proteins. Editing of the mRNA that encodes actin crosslinking protein Filamin A (FLNA) mediates a Q-to-R transition in the interactive C-terminal region. While FLNA editing is conserved among vertebrates, its physiological function remains unclear. Here, we show that cardiovascular tissues in humans and mice show massive editing and that FLNA RNA is the most prominent substrate. Patient-derived RNA-Seq data demonstrate a significant drop in FLNA editing associated with cardiovascular diseases. Using mice with only impaired FLNA editing, we observed increased vascular contraction and diastolic hypertension accompanied by increased myosin light chain phosphorylation, arterial remodeling, and left ventricular wall thickening, which eventually causes cardiac remodeling and reduced systolic output. These results demonstrate a causal relationship between RNA editing and the development of cardiovascular disease indicating that a single epitranscriptomic RNA modification can maintain cardiovascular health.


Related Papers

No related papers found

Powered by citation graph analysis